Recent advances in the synthesis and biomedical applications of heterocyclic no-donors
Nitric oxide (NO) is a key signaling molecule that acts in various physiological processes such as cellular metabolism, vasodilation and transmission of nerve impulses. A wide number of vascular diseases as well as various immune and neurodegenerative disorders were found to be directly associated with a disruption of NO production in living organisms. These issues justify a constant search of novel NO-donors with improved pharmacokinetic profiles and prolonged action. In a series of known structural classes capable of NO release, heterocyclic NO-donors are of special importance due to their increased hydrolytic stability and low toxicity. It is no wonder that synthetic and biochemical investigations of heterocyclic NO-donors have emerged significantly in recent years. In this review, we summarized recent advances in the synthesis, reactivity and biomedical applications of promising heterocyclic NO-donors (furoxans, sydnone imines, pyridazine dioxides, azasydnones). The synthetic potential of each heterocyclic system along with biochemical mechanisms of action are emphasized.
Citations by journals
1
2
3
|
|
Russian Chemical Bulletin
|
Russian Chemical Bulletin
3 publications, 15%
|
MolBank
|
MolBank
2 publications, 10%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 5%
|
Journal of Molecular Structure
|
Journal of Molecular Structure
1 publication, 5%
|
Angewandte Chemie - International Edition
|
Angewandte Chemie - International Edition
1 publication, 5%
|
Angewandte Chemie
|
Angewandte Chemie
1 publication, 5%
|
ACS applied materials & interfaces
|
ACS applied materials & interfaces
1 publication, 5%
|
New Journal of Chemistry
|
New Journal of Chemistry
1 publication, 5%
|
Agrochemicals
|
Agrochemicals
1 publication, 5%
|
Green Chemistry
|
Green Chemistry
1 publication, 5%
|
ACS Omega
|
ACS Omega
1 publication, 5%
|
Advances in Heterocyclic Chemistry
|
Advances in Heterocyclic Chemistry
1 publication, 5%
|
Molecules
|
Molecules
1 publication, 5%
|
RSC Medicinal Chemistry
|
RSC Medicinal Chemistry
1 publication, 5%
|
Mendeleev Communications
|
Mendeleev Communications
1 publication, 5%
|
Journal of Organometallic Chemistry
|
Journal of Organometallic Chemistry
1 publication, 5%
|
Stresses
|
Stresses
1 publication, 5%
|
1
2
3
|
Citations by publishers
1
2
3
4
5
6
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
6 publications, 30%
|
Elsevier
|
Elsevier
4 publications, 20%
|
Springer Nature
|
Springer Nature
3 publications, 15%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
3 publications, 15%
|
Wiley
|
Wiley
2 publications, 10%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 10%
|
1
2
3
4
5
6
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.